High-titer adenovirus vector production in 293s cell perfusion culture

Biotechnology Progress

Volumn 20, Issue 3, 2004, Pages 858-863

  Cortin, Valérie ^a   Thibault, Jules ^b   Jacob, Danielle ^c   Garnier, Alain ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; FILTRATION; GROWTH KINETICS; PROTEINS; VIRUSES;

FLOW FILTRATION DEVICES; RECOMBINANT ADENOVIRUS PRODUCTION;

BIOTECHNOLOGY;

ADENOVIRUS; ARTICLE; BIOREACTOR; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; EVALUATION; FIBROBLAST; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS CULTURE;

ADENOVIRIDAE; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; FIBROBLASTS; GENETIC VECTORS; HUMANS; VIRUS CULTIVATION;

ADENOVIRIDAE;

EID: 2942735393     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp034237l     Document Type: Article

References (15)

1. Wu, N.; Ataai, M. M. Production of Viral Vectors for Gene Therapy Applications. Curr. Opin. Biotechnol. 2000, 11, 205-208.
2. Marchisone, C.; et al. Progress Towards Gene Therapy for Cancer. J. Exp. Clin. Cancer Res. 2000, 19(3), 261-270.
3. Krasnykh, V.; et al. Advanced Generation Adenoviral Vectors Possess Augmented Gene Transfer Efficiency Based upon Coxsackie Adenovirus Receptor-Independent Cellular Entry Capacity. Cancer Res. 2000, 60, 6784-6787.
4. www.wiley.co.uk/genemed., 2001.
5. 2, and Temperature on R-Adenovirus Production. Biotechnol. Prog. 2003, 19, 202-208.
6. Griffiths, J. B. Animal Cell Culture Processes - Batch or Continuous? J. Biotechnol. 1992, 22, 21-30.
7. Garnier, A.; et al. Scale-up of the Adenovirus Expression System for the Production of Recombinant Protein in Human 293S Cells. Cytotechnology 1994, 15, 145-155.
8. Nadeau, I.; et al. Improvement of Recombinant Protein Production with Human Adenovirus/293S Expression System Using Fed-Batch Strategies. Biotechnol. Bioeng. 1996, 51, 613-623.
9. Bibila, T. A.; Robinson, D. K. On Pursuit of the Optimal Fed-Batch Process for Monoclonal Antibody Production. Biotechnol. Prog. 1995, 11, 1-13.
10. Woodside, S. M.; Bowen, B. D.; Piret, J. M. Mammalian Cell Retention Devices for Stirred Perfusion Bioreactors. Cytotechnology 1998, 28, 163-175.
11. Gardner, T. A.; et al. Serum-Free Recombinant Production of Adenovirus Using a Hollow Fiber Capillary System. Biotechniques 2001, 30(2), 422-7.
12. Nadeau, I.; Kamen, A. Production of Adenovirus Vector for Gene Therapy. Biotechnol. Adv. 2003, 20(7-8), 475-89.
13. Graham, F. L.; et al. Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5. J. Gen. Virol. 1977, 36(1), 59-74.
14. Côté, J.; et al. Study of Adenovirus Production in Serum-Free 293SF Suspension Culture by GFP-Expression Monitoring. Biotechnol. Prog. 1997, 13, 709-714.
15. Castilho, L. R.; Medronho, R. A. Cell Retention Devices for Suspended-Cell Perfusion Cultures. Adv. Biochem. Eng. Biotechnol. 2002, 74, 129-69.